DK0514789T3 - - Google Patents

Info

Publication number
DK0514789T3
DK0514789T3 DK92108250.9T DK92108250T DK0514789T3 DK 0514789 T3 DK0514789 T3 DK 0514789T3 DK 92108250 T DK92108250 T DK 92108250T DK 0514789 T3 DK0514789 T3 DK 0514789T3
Authority
DK
Denmark
Prior art keywords
propylxanthine
oxohexyl
prophylaxis
pharmaceuticals
interruption
Prior art date
Application number
DK92108250.9T
Other languages
Danish (da)
English (en)
Inventor
John Dr Grome
Viera Dr Danielisova
Ralf Dr Kolvenbach
Hans-Peter Prof Dr Schubert
Ernst J Dr Schneider
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0514789T3 publication Critical patent/DK0514789T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
DK92108250.9T 1991-05-23 1992-05-15 DK0514789T3 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4116799 1991-05-23

Publications (1)

Publication Number Publication Date
DK0514789T3 true DK0514789T3 (sv) 1997-02-17

Family

ID=6432229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92108250.9T DK0514789T3 (sv) 1991-05-23 1992-05-15

Country Status (16)

Country Link
US (1) US5475002A (sv)
EP (1) EP0514789B1 (sv)
JP (1) JP3193767B2 (sv)
KR (1) KR100219011B1 (sv)
AT (1) ATE142498T1 (sv)
AU (1) AU651205B2 (sv)
CA (1) CA2069202C (sv)
DE (1) DE59207086D1 (sv)
DK (1) DK0514789T3 (sv)
ES (1) ES2093138T3 (sv)
GR (1) GR3021039T3 (sv)
HU (1) HU207798B (sv)
IE (1) IE75890B1 (sv)
IL (1) IL101953A (sv)
TW (1) TW207497B (sv)
ZA (1) ZA923747B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0573617A1 (en) * 1991-05-24 1993-12-15 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US6413976B1 (en) 1999-04-06 2002-07-02 Trustees Of Dartmouth College Compositions and method for decreasing neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤

Also Published As

Publication number Publication date
CA2069202A1 (en) 1992-11-24
JPH05139976A (ja) 1993-06-08
EP0514789B1 (de) 1996-09-11
KR100219011B1 (ko) 1999-09-01
GR3021039T3 (en) 1996-12-31
US5475002A (en) 1995-12-12
ATE142498T1 (de) 1996-09-15
HU207798B (en) 1993-06-28
DE59207086D1 (de) 1996-10-17
EP0514789A1 (de) 1992-11-25
IL101953A (en) 1995-07-31
ES2093138T3 (es) 1996-12-16
HUT61469A (en) 1993-01-28
IE75890B1 (en) 1997-09-24
ZA923747B (en) 1992-12-30
IL101953A0 (en) 1992-12-30
IE921658A1 (en) 1992-12-02
AU651205B2 (en) 1994-07-14
AU1706392A (en) 1992-11-26
CA2069202C (en) 2003-12-09
TW207497B (sv) 1993-06-11
HU9201695D0 (en) 1992-08-28
JP3193767B2 (ja) 2001-07-30

Similar Documents

Publication Publication Date Title
MY103352A (en) Piperazinyl-heterocyclic compounds
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
AU4732989A (en) Pyrimidines and their pharmaceutical acceptable salts thereof, and their use as medicines
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
EP0550006A3 (en) Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
CA2148194A1 (en) Cyclopeptides of the formula i
CA2006267A1 (en) Method of treating herpesviruses
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
DK0514789T3 (sv)
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
AU670491C (en) Pharmaceutical for the treatment of skin disorders
EP0147707A3 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
HK175896A (en) Medicament for the treatment of cardiac insufficiency
ZA877454B (en) Therapeutic agent for the treatment of peptic ulcer disease
EP0355612A3 (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
NO874241D0 (no) Terapeutisk aktive salter.
FI950010A0 (sv) Användning av bradykininantagonister för framställning av läkemedel för behandling av virussjukdomar
HU9200025D0 (en) Medical preparations for treating depression
HU9202229D0 (en) Method for manufacturing new pharmaceutical preparatives containing 2-oxo-benzimidaazoline-1-carboxylic acid derivatives
FI890173A (fi) Isoxazoler med nootropisk verkan.
JPS6485952A (en) Active compound for remedy of cardiovascular system
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser